DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09
NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓

Tirzepatide: the medication, the brands, and the whole price landscape

Tirzepatide is a once-weekly GIP/GLP-1 dual receptor agonist, FDA-approved as Zepbound (chronic weight management, plus obstructive sleep apnea) and Mounjaro (type 2 diabetes). In the SURMOUNT-5 head-to-head it averaged about 20% body-weight reduction versus 14% for semaglutide. Cash prices in 2026: brand vials $299–$449/mo via LillyDirect↗; verified compounded programs $215–$597/mo all-in — a lane legally limited since 2025 to patient-specific 503A prescriptions with documented clinical need.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

How the market prices it

Standard titration steps 2.5 → 5 → 7.5 → 10 mg weekly, with 12.5 and 15 mg available — which is why pricing structure decides your year: dose-flat programs (NexLife at $215) bill the ladder identically at every rung, while tiered programs re-price each step and advertise only the bottom one. Brand pricing has its own structure: LillyDirect's vial program holds $449 at 7.5–15 mg only with refills inside a 45-day window. The working pages: the ranked market, the market in prose, compounded vs Zepbound, the 12-month math, and the regulatory timeline.

Efficacy figures are trial averages for the approved products, not predictions for anyone, and not claims about compounded copies; clinical decisions belong with a licensed prescriber.